What’s Driving Growth in the Prostate Cancer Diagnostics Market? Insights into Key Trends and Opportunities
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the prostate cancer diagnostics market grown over the years?
The market for prostate cancer diagnostics has seen substantial growth in recent times. The market, which was worth $4.43 billion in 2024, is anticipated to reach $5.03 billion in 2025, expanding at a compound annual growth rate (CAGR) of 13.6%. The observed market growth in the past could be attributed to factors such as a growing elderly population, advancements in medical imaging techniques, increased awareness and screening initiatives, public health interventions, and improved biopsy techniques.
What Is the forecasted market size and growth rate for the prostate cancer diagnostics market?
In the upcoming years, the prostate cancer diagnostics market is projected to experience a significant expansion, reaching $8.17 billion in 2029 with an annual growth rate of 12.9%. Factors contributing to this anticipated growth include artificial intelligence integration, the rise of telemedicine in cancer screening, developments in genomic profiling, patient-oriented strategies, and the use of multiparametric MRI for diagnosis. Key trends for the forecast period encompass liquid biopsy technologies, advancements in detecting biomarkers, clinical research and development, the incorporation of digital pathology, and the emergence of multiplex biomarker assays.
Get your prostate cancer diagnostics market report here!
https://www.thebusinessresearchcompany.com/report/prostate-cancer-diagnostics-global-market-report
What are the major factors driving growth in the prostate cancer diagnostics market?
The growth of the prostate cancer diagnostics market is likely to be spurred by an escalated prostate cancer incidence rate. Prostate cancer, a condition that originates in the prostate gland – a key element in male and female reproductive systems – can be detected early with the help of diagnostics. This incorporates tests such as the prostate-specific antigen (PSA) test and advanced imaging techniques. Looking at a specific instance, the American Cancer Society (ACS) reported in January 2023 that there are projected to be around 288,300 new instances of prostate cancer and 34,700 deaths due to the disease in the same year. Consequently, the rising incidence of prostate cancer is set to drive the growth of the prostate cancer diagnostics market.
What key areas define the segmentation of the global prostate cancer diagnostics Market?
The prostate cancer diagnostics market covered in this report is segmented –
1) By Products: Instruments, Reagents And Consumables, Accessories
2) By Test Type: Preliminary Tests, Confirmatory Tests
3) By Prostate Cancer: Squamous Cell Cancer, Small Cell Carcinoma, Transitional Cell Cancer, Prostatic Adenocarcinoma, Ductal Adenocarcinoma, Small Cell Prostate Cancer, Acinar Adenocarcinoma
4) By Peer Groups: Adult, Pediatric, Geriatrics
5) By End User: Hospitals, Independent Diagnostic Laboratories, Cancer Research Institutes, Other End-Users
Subsegments:
1) By Instruments: Biopsy Instruments, Imaging Devices, Digital Rectal Examination Tools
2) By Reagents And Consumables: Diagnostic Assay Kits, Staining Reagents, Sample Collection Materials
3) By Accessories: Biopsy Guides, Specimen Handling Accessories, Calibration And Maintenance Tools
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12003&type=smp
What are the top market players propelling the growth of the prostate cancer diagnostics industry?
Major companies operating in the prostate cancer diagnostics market include F. Hoffman-La Roche AG, Bayer AG, Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Siemens Healthineers AG, Becton Dickinson and Company, Agilent Technologies Inc., Hologic Inc, Biomerieux SA, Beckman Coulter Inc., Qiagen N.V., EXACT Sciences Corporation, Diasorin S.P.A., OPKO Health Inc., Myriad Genetics Inc., Cepheid Inc, NeoGenomics Laboratories Inc., Guardant Health Inc, GRAIL Inc, Fujirebio Diagnostics Inc., Ambry Genetics Corporation, MDxHealth SA, Biocept Inc., Blue Earth Therapeutics Ltd, Exosome Diagnostics Inc., Dana-Farber Cancer Institute, Cellanyx Diagnostics Inc., A3P Biomedical AB
What are the key trends shaping the future of the prostate cancer diagnostics market?
Key technological advancements are becoming a predominant trend in the prostate cancer diagnostics market. Companies leading in the prostate cancer diagnostics field are leveraging the power of innovative artificial intelligence-based tools for prostate cancer diagnosis to maintain their market standing. For example, Qritive, a company that specialises in diagnostic tools based in Singapore, unveiled QAi Prostate in March 2023, a sophisticated AI-assisted prostate cancer diagnosis instrument for pathologists. These instruments incorporate complex machine learning algorithms capable of pinpointing the prostatic adenocarcinoma area and examining entire slide images of prostate core needle biopsies. This technology supports pathologists in making accurate diagnoses in a swift manner, thereby reducing the treatment timeline.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12003
What regions are dominating the prostate cancer diagnostics market growth?
North America was the largest region in the prostate cancer diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prostate cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Commercial And Service Industry Machinery Global Market Report 2024
Machinery Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/machinery-global-market-report
Agriculture, Construction, And Mining Machinery Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
